Ratings by Goldman Sachs (Paul Choi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/17/2026 | Edgewise Therapeutics | EWTX | Maintain | Neutral (N/A) |
|
Details | ||
| 6/2/2026 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2026 | Regenxbio Inc. | RGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2026 | Lantheus Holdings | LNTH | Maintain | Neutral (N/A) |
|
Details | ||
| 4/28/2026 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2026 | Corvus Pharmaceuticals | CRVS | New Coverage | Buy (N/A) |
15.11 (12.63) |
-16.41% | Details | |
| 4/13/2026 | Spyre | SYRE | Maintain | Early-Stage Biotech (N/A) |
|
Details | ||
| 3/6/2026 | Hutchison China MediTech Ltd. | HCM | Maintain | Neutral (N/A) |
|
Details | ||
| 3/2/2026 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Gossamer Bio Inc. | GOSS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2026 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | Regenxbio Inc. | RGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/29/2026 | Regenxbio Inc. | RGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 12/19/2025 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | Cytokinetics | CYTK | Upgrade | Buy (Neutral) |
59.82 (80.01) |
33.75% | Details | |
| 12/3/2025 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 11/13/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 10/30/2025 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2025 | Arvinas Inc. | ARVN | Downgrade | Sell (Neutral) |
9.80 (8.14) |
-16.94% | Details | |
| 10/8/2025 | Lantheus Holdings | LNTH | Downgrade | Neutral (Buy) |
52.70 (106.03) |
101.2% | Details | |
| 10/7/2025 | Soleno Therapeutics Inc. | SLNO | New Coverage | Buy (N/A) |
59.21 (53.01) |
-10.47% | Details | |
| 9/26/2025 | Gossamer Bio Inc. | GOSs | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2025 | Edgewise Therapeutics | EWTX | New Coverage | Neutral (N/A) |
15.09 (38.83) |
157.32% | Details | |
| 9/17/2025 | Entrada Therapeutics | TRDA | New Coverage | Early-Stage Biotech (N/A) |
5.06 (7.24) |
43.08% | Details | |
| 9/17/2025 | Exelixis | EXEL | New Coverage | Buy (N/A) |
39.01 (51.34) |
31.61% | Details | |
| 9/5/2025 | Regenxbio Inc. | RGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/21/2025 | Dynavax Technologies | DVAX | Maintain | Sell (N/A) |
|
Details | ||
| 8/19/2025 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 8/8/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Lantheus Holdings | LNTH | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2025 | Amarin Corporation | AMRN | Maintain | Sell (N/A) |
|
Details | ||
| 6/9/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/22/2025 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/19/2025 | Gossamer Bio Inc. | GOSS | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2025 | Gossamer Bio Inc. | GOSS | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2025 | Arvinas Inc. | ARVN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2025 | Xenon Pharmaceuticals | XENE | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2025 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2025 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2025 | Regenxbio Inc. | RGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2025 | Gossamer Bio Inc. | GOSS | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2025 | Esperion Therapeutics | ESPR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2025 | Dynavax Technologies | DVAX | Maintain | Sell (N/A) |
|
Details | ||
| 4/16/2025 | Arvinas Inc. | ARVN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2025 | Amarin Corporation | AMRN | Maintain | Sell (N/A) |
|
Details | ||
| 3/13/2025 | Arvinas Inc. | ARVN | Downgrade | Neutral (Buy) |
8.30 (9.80) |
18.07% | Details | |
| 3/10/2025 | Phathom Pharmaceuticals | PHAT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Regenxbio Inc. | RGNX | Downgrade | Neutral (Buy) |
8.21 (9.95) |
21.19% | Details | |
| 2/11/2025 | Dynavax Technologies | DVAX | Downgrade | Sell (Neutral) |
13.15 (15.50) |
17.87% | Details | |
| 1/15/2025 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2025 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2025 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2024 | Esperion Therapeutics | ESPR | New Coverage | Neutral (N/A) |
2.33 (3.16) |
35.62% | Details | |
| 12/18/2024 | Lantheus Holdings | LNTH | New Coverage | Buy (N/A) |
93.48 (52.70) |
-43.62% | Details | |
| 12/3/2024 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 11/25/2024 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2024 | Cytokinetics | CYTK | Maintain | Neutral (N/A) |
|
Details | ||
| 10/9/2024 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 9/16/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Cytokinetics | CYTK | Maintain | Neutral (N/A) |
|
Details | ||
| 9/4/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Cytokinetics | CYTK | Maintain | Neutral (N/A) |
|
Details | ||
| 8/13/2024 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/13/2024 | Cytokinetics | CYTK | Downgrade | Neutral (Buy) |
55.79 (59.82) |
7.22% | Details | |
| 8/12/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Phathom Pharmaceuticals | PHAT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/6/2024 | Dynavax Technologies | DVAX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/1/2024 | Hutchison China MediTech Ltd. | HCM | Maintain | Neutral (N/A) |
|
Details | ||
| 7/31/2024 | FibroGen | FGEN | Maintain | Sell (N/A) |
|
Details | ||
| 6/21/2024 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 6/14/2024 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 6/7/2024 | Regenxbio Inc. | RGNX | New Coverage | Buy (N/A) |
14.52 (9.95) |
-31.47% | Details | |
| 5/30/2024 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 5/20/2024 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 5/14/2024 | Dynavax Technologies | DVAX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/6/2024 | Gossamer Bio Inc. | GOSS | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2024 | Dynavax Technologies | DVAX | New Coverage | Neutral (N/A) |
13.04 (15.50) |
18.87% | Details | |
| 2/1/2024 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
39.47 (8.14) |
-79.38% | Details | |
| 12/28/2023 | Cytokinetics | CYTK | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 11/10/2023 | Hutchison China MediTech Ltd. | HCM | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2023 | Cytokinetics | CYTK | New Coverage | Buy (N/A) |
35.85 (55.79) |
55.62% | Details | |
| 11/3/2023 | Phathom Pharmaceuticals | PHAT | Maintain | Neutral (N/A) |
|
Details | ||
| 9/18/2023 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 7/28/2023 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 7/25/2023 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2023 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2023 | Amarin Corporation | AMRN | Maintain | Sell (N/A) |
|
Details | ||
| 7/17/2023 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2023 | FibroGen | FGEN | Maintain | Sell (N/A) |
|
Details | ||
| 5/17/2023 | PTC Therapeutics | PTCT | Maintain | Sell (N/A) |
|
Details | ||
| 4/18/2023 | Kinnate Biopharma | KNTE | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2023 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Gossamer Bio Inc. | GOSS | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | FibroGen | FGEN | Maintain | Sell (N/A) |
|
Details | ||
| 2/21/2023 | FibroGen | FGEN | Maintain | Sell (N/A) |
|
Details | ||
| 2/21/2023 | Vir Biotechnology | VIR | Upgrade | Buy (Neutral) |
25.57 (10.16) |
-60.27% | Details | |
| 12/14/2022 | Xenon Pharmaceuticals | XENE | New Coverage | Buy (N/A) |
38.19 (54.61) |
43% | Details | |
| 12/14/2022 | PTC Therapeutics | PTCT | New Coverage | Sell (N/A) |
39.44 (82.13) |
108.24% | Details | |
| 11/8/2022 | FibroGen | FGEN | Maintain | Sell (N/A) |
|
Details | ||
| 10/20/2022 | Ascendis Pharma | ASND | New Coverage | Buy (N/A) |
112.19 (238.59) |
112.67% | Details | |
| 10/20/2022 | Gossamer Bio Inc. | GOSS | New Coverage | Buy (N/A) |
12.50 (0.17) |
-98.64% | Details | |
| 10/18/2022 | NGM Biopharmaceuticals | NGM | Downgrade | Neutral (Buy) |
11.55 (1.54) |
-86.67% | Details | |
| 8/8/2022 | Hutchison China MediTech Ltd. | HCM | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2022 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2022 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2022 | Hutchison China MediTech Ltd. | HCM | Maintain | Neutral (N/A) |
|
Details | ||
| 4/4/2022 | Silverback Therapeutics | SBTX | Downgrade | Neutral (Buy) |
3.51 (5.87) |
67.24% | Details | |
| 3/22/2022 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2022 | FibroGen | FGEN | Maintain | Sell (N/A) |
|
Details | ||
| 2/22/2022 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2022 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2022 | Vir Biotechnology | VIR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2022 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2022 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2022 | Hutchison China MediTech Ltd. | HCM | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2022 | Esperion Therapeutics | ESPR | Maintain | Sell (N/A) |
|
Details | ||
| 2/16/2022 | Clovis Oncology | CLVS | Maintain | Sell (N/A) |
|
Details | ||
| 2/16/2022 | Amarin Corporation | AMRN | Maintain | Sell (N/A) |
|
Details | ||
| 2/16/2022 | Allakos Inc. | ALLK | Maintain | Neutral (N/A) |
|
Details | ||
| 12/28/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2021 | Allakos Inc. | ALLK | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2021 | Silverback Therapeutics | SBTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Puma Biotechnology | PBYI | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2021 | Amarin Corporation | AMRN | Maintain | Sell (N/A) |
|
Details | ||
| 10/6/2021 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2021 | Axcella Health Inc. | AXLA | Downgrade | Neutral (Buy) |
3.09 (4.58) |
48.22% | Details | |
| 9/22/2021 | Frequency Therapeutics | FREQ | Downgrade | Neutral (Buy) |
7.23 (0.30) |
-95.85% | Details | |
| 9/22/2021 | Hutchison China MediTech Ltd. | HCM | Downgrade | Neutral (Buy) |
38.18 (10.16) |
-73.39% | Details | |
| 9/22/2021 | Vir Biotechnology | VIR | Downgrade | Neutral (Buy) |
49.70 (10.16) |
-79.56% | Details | |
| 9/22/2021 | FibroGen | FGEN | Downgrade | Sell (Neutral) |
11.27 (9.71) |
-13.84% | Details | |
| 9/22/2021 | PMV Pharmaceuticals Inc. | PMVP | Upgrade | Buy (Neutral) |
26.84 (1.21) |
-95.49% | Details | |
| 9/17/2021 | Silverback Therapeutics | SBTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2021 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2021 | FibroGen | FGEN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/6/2021 | Puma Biotechnology | PBYI | Maintain | Sell (N/A) |
|
Details | ||
| 7/19/2021 | FibroGen | FGEN | Maintain | Neutral (N/A) |
|
Details | ||
| 7/14/2021 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/25/2021 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2021 | Allakos Inc. | ALLK | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/14/2021 | Odonate Therapeutics | ODT | Maintain | Sell (N/A) |
|
Details | ||
| 5/13/2021 | Frequency Therapeutics | FREQ | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2021 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2021 | Phathom Pharmaceuticals | PHAT | Upgrade | Neutral (Sell) |
32.97 (10.86) |
-67.06% | Details | |
| 5/12/2021 | Amarin Corporation | AMRN | Downgrade | Sell (Neutral) |
4.59 (15.97) |
247.93% | Details | |
| 5/11/2021 | FibroGen | FGEN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2021 | Odonate Therapeutics | ODT | Maintain | Sell (N/A) |
|
Details | ||
| 3/22/2021 | BridgeBio Pharma | BBIO | Maintain | Neutral (N/A) |
|
Details | ||
| 3/19/2021 | Foghorn Therapeutics | FHTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2021 | Vir Biotechnology | VIR | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2021 | Hutchison China MediTech Ltd. | HCM | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2021 | Vir Biotechnology | VIR | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2021 | Magenta Therapeutics | MGTA | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2021 | PMV Pharmaceuticals Inc. | PMVP | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/1/2021 | Allakos Inc. | ALLK | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2021 | Vir Biotechnology | VIR | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2021 | Amarin Corporation | AMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/25/2021 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2021 | Odonate Therapeutics | ODT | Maintain | Sell (N/A) |
|
Details | ||
| 2/9/2021 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2021 | Esperion Therapeutics | ESPR | Downgrade | Sell (Neutral) |
34.08 (2.33) |
-93.16% | Details | |
| 2/9/2021 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
68.28 (68.63) |
0.51% | Details | |
| 2/1/2021 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2021 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2021 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (Buy) |
|
Details | ||
| 1/7/2021 | Radius Health | RDUS | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2021 | Myovant Sciences Ltd. | MYOV | Downgrade | Neutral (Buy) |
24.07 (26.98) |
12.09% | Details | |
| 12/30/2020 | Hutchison China MediTech Ltd. | HCM | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2020 | Silverback Therapeutics | SBTX | New Coverage | Buy (N/A) |
35.77 (5.87) |
-83.59% | Details | |
| 12/28/2020 | Kinnate Biopharma | KNTE | New Coverage | Buy (N/A) |
37.20 (2.65) |
-92.88% | Details | |
| 12/11/2020 | Phathom Pharmaceuticals | PHAT | Maintain | Sell (N/A) |
|
Details | ||
| 11/10/2020 | Spring Works Therapeutics | SWTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Allakos Inc. | ALLK | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2020 | Array Technologies | ARRY | New Coverage | Buy (N/A) |
39.34 (7.90) |
-79.92% | Details | |
| 10/20/2020 | PMV Pharmaceuticals Inc. | PMVP | New Coverage | Neutral (N/A) |
35.99 (1.21) |
-96.64% | Details | |
| 9/14/2020 | Vir Biotechnology | VIR | Upgrade | Buy (Neutral) |
28.28 (10.16) |
-64.07% | Details | |
| 9/3/2020 | Amarin Corporation | AMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/27/2020 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/17/2020 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2020 | Frequency Therapeutics | FREQ | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Pandion Therapeutics | PAND | New Coverage | Buy (N/A) |
19.11 (60.05) |
214.23% | Details | |
| 8/10/2020 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/6/2020 | Axcella Health Inc. | AXLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2020 | Axcella Health Inc. | AXLA | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2020 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2020 | Odonate Therapeutics | ODT | Maintain | Sell (N/A) |
|
Details | ||
| 7/15/2020 | Viela Bio | VIE | Upgrade | Neutral (Sell) |
38.35 (53.01) |
38.23% | Details | |
| 7/1/2020 | Global Blood Therapeutics | GBT | Upgrade | Buy (Neutral) |
66.50 (68.49) |
2.99% | Details | |
| 6/29/2020 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Neurocrine Bio. | NBIX | Downgrade | Neutral (Buy) |
130.36 (161.44) |
23.84% | Details | |
| 6/26/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2020 | Phathom Pharmaceuticals | PHAT | Downgrade | Sell (Neutral) |
41.55 (10.86) |
-73.86% | Details | |
| 6/9/2020 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Immunomedics | IMMU | Maintain | Neutral (N/A) |
|
Details | ||
| 6/8/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2020 | Amarin Corporation | AMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 6/8/2020 | Magenta Therapeutics | MGTA | Upgrade | Buy (Neutral) |
9.99 (0.70) |
-92.99% | Details | |
| 6/5/2020 | Viela Bio | VIE | Maintain | Sell (N/A) |
|
Details | ||
| 6/5/2020 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Kiniksa | KNSA | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Amarin Corporation | AMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 6/4/2020 | Viela Bio | VIE | Maintain | Sell (N/A) |
|
Details | ||
| 6/2/2020 | Viela Bio | VIE | Maintain | Sell (N/A) |
|
Details | ||
| 6/2/2020 | Axcella Health Inc. | AXLA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | Puma Biotechnology | PBYI | Maintain | Sell (N/A) |
|
Details | ||
| 5/6/2020 | Clovis Oncology | CLVS | Maintain | Sell (N/A) |
|
Details | ||
| 4/27/2020 | Radius Health | RDUS | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2020 | Hutchison China MediTech Ltd. | HCM | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2020 | Global Blood Therapeutics | GBT | Maintain | Neutral (N/A) |
|
Details | ||
| 4/27/2020 | Exelixis | EXEL | Maintain | Neutral (N/A) |
|
Details | ||
| 4/24/2020 | Immunomedics | IMMu | Upgrade | Neutral (Sell) |
21.97 (87.86) |
299.91% | Details | |
| 4/22/2020 | Applied Therapeutics | APLT | New Coverage | Buy (N/A) |
35.27 (0.10) |
-99.72% | Details | |
| 4/6/2020 | Acceleron Pharma | XLRN | Downgrade | Sell (Neutral) |
83.60 (178.75) |
113.82% | Details | |
| 4/6/2020 | Viela Bio | VIE | Downgrade | Sell (Neutral) |
31.99 (53.01) |
65.71% | Details | |
| 3/31/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2020 | Amarin Corporation | AMRN | Downgrade | Neutral (Buy) |
13.58 (15.97) |
17.6% | Details | |
| 3/30/2020 | Magenta Therapeutics | MGTA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/30/2020 | Myovant Sciences Ltd. | MYOV | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2020 | FibroGen | FGEN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/30/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2020 | Immunomedics | IMMU | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2020 | Nektar Therapeutics | NKTR | Upgrade | Neutral (Sell) |
17.51 (66.69) |
280.87% | Details | |
| 3/26/2020 | Frequency Therapeutics | FREQ | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2020 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2020 | Vir Biotechnology | VIR | Downgrade | Neutral (Buy) |
33.77 (10.16) |
-69.91% | Details | |
| 3/13/2020 | Amarin Corporation | AMRN | Upgrade | Buy (Neutral) |
12.56 (13.58) |
8.12% | Details | |
| 3/12/2020 | Aimmune Therapeutics | AIMT | Maintain | Neutral (N/A) |
|
Details | ||
| 3/10/2020 | Acceleron Pharma | XLRN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/3/2020 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/2/2020 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/2/2020 | Nektar Therapeutics | NKTR | Maintain | Sell (N/A) |
|
Details | ||
| 2/28/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Neutral (N/A) |
|
Details | ||
| 2/25/2020 | Esperion Therapeutics | ESPR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/24/2020 | Esperion Therapeutics | ESPR | Maintain | Neutral (N/A) |
|
Details | ||
| 2/21/2020 | Puma Biotechnology | PBYI | Maintain | Sell (N/A) |
|
Details | ||
| 2/20/2020 | Odonate Therapeutics | ODT | Maintain | Sell (N/A) |
|
Details | ||
| 2/20/2020 | Hutchison China MediTech Ltd. | HCM | New Coverage | Buy (N/A) |
27.42 (10.16) |
-62.95% | Details | |
| 2/11/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2020 | Biohaven Pharmaceutical Holding | BHVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2020 | Axcella Health Inc. | AXLA | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2020 | Allakos Inc. | ALLK | New Coverage | Neutral (N/A) |
74.04 (0.33) |
-99.55% | Details | |
| 2/4/2020 | Viela Bio | VIE | Downgrade | Neutral (Buy) |
39.35 (53.01) |
34.71% | Details | |
| 1/29/2020 | Acceleron Pharma | XLRN | Maintain | Neutral (N/A) |
|
Details | ||
| 1/28/2020 | Acceleron Pharma | XLRN | Maintain | Neutral (N/A) |
|
Details | ||
| 12/17/2019 | Amarin Corporation | AMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 12/6/2019 | Magenta Therapeutics | MGTA | New Coverage | Neutral (N/A) |
13.12 (0.70) |
-94.66% | Details | |
| 12/6/2019 | Odonate Therapeutics | ODT | New Coverage | Sell (N/A) |
34.98 (1.12) |
-96.8% | Details | |
| 12/6/2019 | Kiniksa | KNSA | New Coverage | Buy (N/A) |
10.05 (59.49) |
491.94% | Details | |
| 11/25/2019 | Global Blood Therapeutics | GBT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/19/2019 | Phathom Pharmaceuticals | PHAT | New Coverage | Neutral (N/A) |
25.87 (10.86) |
-58.02% | Details | |
| 11/14/2019 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/14/2019 | NGM Biopharmaceuticals | NGM | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2019 | Axcella Health Inc. | AXLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2019 | Vir Biotechnology | VIR | New Coverage | Buy (N/A) |
15.00 (10.16) |
-32.27% | Details | |
| 11/4/2019 | Exelixis | EXEL | Maintain | Neutral (N/A) |
|
Details | ||
| 10/29/2019 | Amarin Corporation | AMRN | Maintain | Neutral (N/A) |
|
Details | ||
| 10/28/2019 | Viela Bio | VIE | New Coverage | Buy (N/A) |
19.65 (53.01) |
169.77% | Details | |
| 10/28/2019 | Frequency Therapeutics | FREQ | New Coverage | Buy (N/A) |
14.05 (0.30) |
-97.86% | Details | |
| 10/25/2019 | Myovant Sciences Ltd. | MYOV | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2019 | Aimmune Therapeutics | AIMT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/24/2019 | Myovant Sciences Ltd. | MYOV | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2019 | Aimmune Therapeutics | AIMT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/15/2019 | Amarin Corporation | AMRN | New Coverage | Neutral (N/A) |
15.22 (15.97) |
4.93% | Details | |
| 10/8/2019 | Spring Works Therapeutics | SWTX | New Coverage | Buy (N/A) |
18.15 (68.20) |
275.76% | Details | |
| 10/8/2019 | Nektar Therapeutics | NKTR | Downgrade | Sell (Buy) |
18.97 (66.69) |
251.56% | Details | |
| 10/8/2019 | Clovis Oncology | CLVS | Maintain | Sell (N/A) |
|
Details | ||
| 10/8/2019 | Puma Biotechnology | PBYI | Downgrade | Sell (Neutral) |
10.01 (8.04) |
-19.68% | Details | |
| 9/16/2019 | Esperion Therapeutics | ESPR | Upgrade | Neutral (Sell) |
36.56 (3.16) |
-91.36% | Details | |
| 8/28/2019 | Myovant Sciences Ltd. | MYOV | New Coverage | Buy (N/A) |
7.86 (24.07) |
206.23% | Details | |
| 8/13/2019 | UroGen Pharma | URGN | Maintain | Neutral (N/A) |
|
Details | ||
| 7/22/2019 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
26.00 (68.63) |
163.96% | Details | |
| 6/3/2019 | Axcella Health Inc. | AXLA | New Coverage | Buy (N/A) |
14.20 (4.58) |
-67.75% | Details | |
| 5/29/2019 | Puma Biotechnology | PBYI | Maintain | Neutral (N/A) |
|
Details | ||
| 5/29/2019 | Acceleron Pharma | XLRN | New Coverage | Neutral (N/A) |
42.06 (178.75) |
324.99% | Details | |
| 5/29/2019 | Global Blood Therapeutics | GBT | New Coverage | Neutral (N/A) |
59.93 (68.49) |
14.28% | Details | |
| 5/29/2019 | FibroGen | FGEN | New Coverage | Neutral (N/A) |
35.57 (9.71) |
-72.7% | Details | |
| 5/29/2019 | Esperion Therapeutics | ESPR | New Coverage | Sell (Neutral) |
52.33 (36.56) |
-30.14% | Details | |
| 5/29/2019 | Clovis Oncology | CLVS | New Coverage | Sell (Neutral) |
16.74 (0.08) |
-99.52% | Details | |
| 5/29/2019 | Radius Health | RDUS | New Coverage | Buy (Neutral) |
21.11 (30.00) |
42.11% | Details | |
| 5/29/2019 | UroGen Pharma | URGN | New Coverage | Neutral (N/A) |
36.52 (35.15) |
-3.75% | Details | |
| 5/13/2019 | Turning Point Therapeutics Inc. | TPTX | New Coverage | Buy (N/A) |
33.48 (76.01) |
127.03% | Details | |
| 5/6/2019 | Biohaven Pharmaceutical Holding | BHVN | New Coverage | Buy (N/A) |
57.14 (10.99) |
-80.77% | Details | |
| 4/29/2019 | NGM Biopharmaceuticals | NGM | New Coverage | Buy (N/A) |
15.57 (1.54) |
-90.11% | Details | |
| 4/26/2019 | The Medicines Company | MDCO | Upgrade | Buy (Neutral) |
29.46 (84.90) |
188.19% | Details | |
| 4/26/2019 | Esperion Therapeutics | ESPR | Upgrade | Neutral (Sell) |
41.91 (52.33) |
24.86% | Details | |
| 12/20/2018 | Aimmune Therapeutics | AIMT | Maintain | Neutral (N/A) |
|
Details | ||
| 12/13/2018 | Array BioPharma | ARRY | New Coverage | Neutral (N/A) |
15.45 (7.90) |
-48.87% | Details | |
| 12/13/2018 | Aimmune Therapeutics | AIMT | New Coverage | Neutral (N/A) |
23.23 (34.49) |
48.47% | Details | |
| 12/13/2018 | The Medicines Company | MDCO | New Coverage | Neutral (N/A) |
20.70 (29.46) |
42.32% | Details | |
| 12/13/2018 | Esperion Therapeutics | ESPR | New Coverage | Sell (N/A) |
52.90 (41.91) |
-20.78% | Details | |
| 12/13/2018 | Nektar Therapeutics | NKTR | New Coverage | Buy (N/A) |
36.43 (66.69) |
83.06% | Details | |
| 12/13/2018 | Neurocrine Bio. | NBIX | New Coverage | Buy (N/A) |
85.76 (130.36) |
52.01% | Details | |
| 11/19/2018 | Puma Biotechnology | PBYI | Upgrade | Neutral (Sell) |
22.61 (8.04) |
-64.44% | Details | |
| 9/17/2018 | Puma Biotechnology | PBYI | New Coverage | Sell (N/A) |
48.35 (22.61) |
-53.24% | Details | |
| 9/17/2018 | Loxo Oncology | LOXO | New Coverage | Neutral (N/A) |
165.38 (234.80) |
41.98% | Details | |
| 9/17/2018 | Exelixis | EXEL | New Coverage | Neutral (N/A) |
16.71 (51.34) |
207.24% | Details | |
| 9/17/2018 | Immunomedics | IMMU | New Coverage | Buy (N/A) |
22.61 (21.97) |
-2.83% | Details |
